Weiss Multi-Strategy Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,000	Closed	-$97K	–	679
2017 Q1	$97K	Buy	+30,000	New	+$73.8K	﹤0.01%	527
2016 Q2	–	Sell	-45,500	Closed	-$240K	–	522
2016 Q1	$240K	Hold	45,500	–	–	0.01%	419
2015 Q4	$357K	Hold	45,500	–	–	0.02%	320
2015 Q3	$384K	Buy	+45,500	New	+$420K	0.02%	338
2014 Q1	–	Sell	-20,749	Closed	-$278K	–	1151
2013 Q4	$287K	Buy	+20,749	New	+$293K	0.01%	836

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's INFI Position: Q2 2017 in Review

Weiss Multi-Strategy Advisers sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 30,000 shares — an estimated $97K sold.

Weiss Multi-Strategy Advisers first reported a position in INFI in Q4 2013 and held it in 5 quarters. The position peaked at $384K in Q3 2015. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

Weiss Multi-Strategy Advisers reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 30,000 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $97K.
Weiss Multi-Strategy Advisers first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's Infinity Pharmaceuticals, Inc. position peaked at $384K in Q3 2015.
74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.